EXECUTIVE SUMMARY
Public–private partnerships (PPPs) have become a mainstream instrument in humanitarian and development finance, but their effectiveness is highly context-dependent. This document surveys the taxonomy of PPP types relevant to humanitarian and development settings, reviews evidence on what works, identifies design principles for accountability and community ownership in fragile contexts, and maps UNFPA's existing and potential private sector engagement. It is written to support the LKYSPP Policy Innovation Lab team working on the challenge: "How might we design innovative PPPs that strengthen community resilience to climate and humanitarian stressors in Asia?"
The core finding is that PPPs in humanitarian settings are not a single instrument but a family of arrangements spanning commodity procurement, blended finance vehicles, platform partnerships, and social impact bonds. Strong evidence exists for a narrow set of models — primarily large-scale health commodity pooling mechanisms (GAVI, the Global Fund, CEPI) and output-based procurement. Evidence for more ambitious "resilience PPPs" in fragile or climate-affected settings is much thinner and contested. The most common design failures are: mission drift toward commercially viable populations, insufficient community ownership mechanisms, inadequate risk-sharing between parties, and short time horizons incompatible with systemic change.
KEY FACTS
- Global PPP market in development: Estimated at USD 130–170 billion annually across all sectors; humanitarian-focused PPPs represent a small subset
- GAVI vaccine financing: Mobilised over USD 21 billion since 2000; covers 495 million children; widely cited as the most successful health-sector PPP
- Global Fund: Has disbursed over USD 50 billion since 2002 for HIV, TB, and malaria; mixed results on sustainability and country ownership
- CEPI (Coalition for Epidemic Preparedness Innovations): USD 2 billion in capital commitments; produced COVID-19 vaccine candidates in record time; PPP with pharmaceutical companies
- Humanitarian private sector engagement size: Estimated at USD 1–3 billion annually directly from private sector to humanitarian operations — a fraction of total humanitarian need (~USD 50+ billion annually)
- UNFPA private sector revenue: Small relative to total budget; primarily pharmaceutical and technology procurement partnerships, not financial partnerships
- Blended finance market: Convergence (2019) estimated USD 140 billion in total assets mobilised through blended finance since 2010 — far below the USD 2.5 trillion SDG investment gap
BACKGROUND AND CONTEXT
Origins: Why PPPs Entered the Development Lexicon
The term "public–private partnership" entered development discourse during the 1990s as governments faced fiscal constraints and donors sought to leverage private capital. The 2002 Monterrey Consensus on Financing for Development formalised the logic: public budgets alone cannot close the financing gap for development goals, so private capital must be mobilised. The 2015 Addis Ababa Action Agenda reinforced this with the concept of "billions to trillions" — mobilising private investment at scale for the SDGs.
In the humanitarian sector, the shift came later. The 2016 World Humanitarian Summit produced the Grand Bargain, which encouraged new forms of partnership between humanitarian actors and the private sector. By 2020, major UN agencies — including UNFPA, UNHCR, WFP, and UNICEF — had established dedicated private sector partnership units, though with varying degrees of strategic coherence.
The COVID-19 pandemic accelerated both the attractiveness and the scrutiny of PPPs. COVAX, the global vaccine sharing mechanism, demonstrated both the potential (rapid platform creation) and the limits (wealthier nations hoarded vaccines; access for low-income countries was slower than projected) of public–private co-design in health emergencies.
Why PPPs Are Particularly Contested in Humanitarian Settings
The humanitarian community has historically been cautious about private sector engagement due to concerns about:
- Mandate distortion: Private actors pursuing profit may avoid the most vulnerable populations (those without purchasing power), undermining humanitarian principles of humanity, neutrality, impartiality, and independence
- Data and privacy: Private sector partners may use beneficiary data for commercial purposes
- Market distortion: Subsidised private services can displace existing community or government providers, creating long-term dependency rather than resilience
- Accountability gaps: Unlike government agencies, private sector partners face no formal accountability to affected populations; complaint mechanisms are weak
These concerns have not disappeared. A 2021 systematic review of private sector engagement in humanitarian settings (IARAN, International Association of Research and News) found that most partnerships remained transactional (donations, in-kind goods) rather than strategic (joint programme design and delivery), and that community participation in PPP design was rare.
TAXONOMY OF PPP TYPES RELEVANT TO HUMANITARIAN/DEVELOPMENT SETTINGS
Type 1: Commodity Procurement Partnerships
Definition: Public agencies pool procurement power to negotiate with private suppliers (pharmaceutical companies, equipment manufacturers) at reduced prices; private suppliers gain predictable demand and reputational access.
Examples in UNFPA's work:
- UNFPA's status as the world's largest multilateral procurer of contraceptives and reproductive health commodities is essentially a sustained commodity PPP. UNFPA negotiates with manufacturers (Bayer, Pfizer, Medicines360, local generic producers) on behalf of governments.
- The Reproductive Health Supplies Coalition (RHSC) is a platform PPP that brings together donors, governments, manufacturers, and NGOs to coordinate supply chains.
Evidence: Strong evidence of cost reduction through pooled procurement. UNFPA's Supplies Partnership generates an estimated $8.40 in direct health and economic benefits per $1 invested (2024 data). Country-level examples show dramatic savings (e.g., Bolivia: UNFPA-procured oral contraceptives at $0.21/cycle vs. ~$1.68 private pharmacy). The broader "20–40% below market" claim appears in some analyses but is not verified in UNFPA's own published procurement statistics — the documented aggregate saving is $28 million over 2017–2021. Limited evidence on whether the partnerships actually strengthen in-country supply chain resilience vs. creating import dependency.
Relevant to the challenge: A resilience-oriented version of this model could include: contracts with regional manufacturers (India, Bangladesh) that build local capacity alongside supply; incentive structures for manufacturers to invest in climate-resilient cold chain logistics in Asia.
Type 2: Blended Finance Vehicles
Definition: Concessional public capital (grants, guarantees, first-loss tranches from governments, DFIs, or foundations) is used to de-risk private investment in areas where commercial returns are insufficient but social returns are high.
Structure variants:
- First-loss guarantees: A public or philanthropic actor absorbs initial losses, making the investment attractive to risk-averse private investors
- Subordinated debt/equity: Public actor takes a junior position; private actor is paid out first, reducing their risk
- Results-based financing (RBF) / Development Impact Bonds (DIBs): Private investor funds upfront service delivery; a public or philanthropic "outcome payer" reimburses only if pre-agreed outcomes are achieved
Examples:
- Temasek's Helios Impact Fund (blended private equity for climate and health in Southeast Asia)
- USAID's Development Credit Authority (now DFC) — loan guarantees that mobilised private lending for healthcare in low-income countries
- The Utkrisht Impact Bond (India): private investors funded quality improvement in maternal health facilities; outcome payer (USAID, MSD) reimbursed if mortality reduction targets met — a rare humanitarian-adjacent DIB
Evidence quality: Weak to moderate. Convergence (Blended Finance Taskforce) analyses suggest that for every USD 1 of concessional public capital deployed, approximately USD 0.37–2.0 of private capital is mobilised — a wide and contested range. Impact on beneficiaries (as opposed to financial returns) is even less well-documented. Criticism: blended finance tends to concentrate in middle-income countries and commercially viable sectors (energy, housing), not in the most fragile, highest-need humanitarian settings.
Relevant to the challenge: The team should engage critically with blended finance claims. Singapore's strong DFI and family office ecosystem creates potential, but the evidence that blended finance reaches climate-affected, vulnerable populations in Asia (Pacific SIDS, flood-prone Bangladesh/Myanmar) is thin.
Type 3: Platform Partnerships / Global Health Mechanisms
Definition: A dedicated legal entity is created in which public, philanthropic, and private actors jointly govern and finance a mandate. The "platform" provides shared services (procurement, technical assistance, monitoring) at lower cost than any actor working alone.
Canonical examples:
- GAVI, the Vaccine Alliance: Brings together WHO, UNICEF, World Bank, Bill & Melinda Gates Foundation, donor governments, developing country governments, civil society, and vaccine manufacturers. Board seats are allocated across constituencies. Widely considered the most successful health PPP by cost-effectiveness metrics (USD 21+ billion mobilised; estimated 10–16 million deaths averted since 2000 per GAVI's own modelling).
- Global Fund to Fight AIDS, Tuberculosis and Malaria: Board includes governments, private sector, civil society, and affected communities. Has disbursed >USD 50 billion. Country Coordinating Mechanisms (CCMs) at the national level formally include civil society representation, though critics note that affected community voices remain weak in many CCMs.
- CEPI: Created after the 2014–16 Ebola outbreak specifically to accelerate vaccine development for epidemic threats. PPP between governments, private foundations, and pharmaceutical companies. Demonstrated speed in COVID-19 response but did not solve equity of access.
Design lessons:
- Ring-fenced financing (separate from annual appropriations) creates predictability that private partners require
- Multi-constituent governance with genuine voice for low-income countries and civil society reduces capture
- Clear mandate boundaries prevent mission drift
- Pre-agreed exit or transition strategies prevent indefinite subsidy dependence
Relevant to the challenge: A platform partnership model adapted for community resilience in Asia could pool Singapore finance capital, UNFPA technical expertise, and Asian government co-financing. The GAVI and Global Fund precedents are the strongest analogues for UNFPA to invoke in partnership design discussions.
Type 4: Output-Based Aid / Social Impact Bonds
Definition: Payment is made to a service provider (government, NGO, or private firm) only when a specified output or outcome is achieved, not on an input basis.
Variants:
- Output-Based Aid (OBA): Provider gets paid per output delivered (e.g., per woman receiving a maternal health check). Common in World Bank programmes.
- Social Impact Bond (SIB): Private investor funds a social programme upfront; a government or philanthropic "commissioner" repays the investor plus a return if pre-agreed outcomes are achieved. First SIB: UK Peterborough Prison (2010).
- Development Impact Bond (DIB): SIB variant where the outcome payer is a donor/philanthropic actor rather than a government — more relevant to developing country contexts.
Humanitarian-specific DIBs: Remain rare and small. The Educate Girls DIB in India (2015–2018) is cited often; it achieved targets and investor return was positive. Attempts to replicate in more fragile contexts have struggled with measurement complexity and political volatility.
Risks in humanitarian contexts:
- Outcome measurement may focus on what is measurable (clinic visits) rather than what matters (health status improvement)
- Providers facing outcome-based payments may cream-skim (serve easier-to-reach populations)
- Short time horizons (3–7 years) poorly suited to building sustainable systems
Relevant to the challenge: DIBs may be worth exploring for specific, measurable components of community resilience (e.g., trained community health workers remaining active after 2 years; contraceptive availability maintained through climate disruptions). They are not appropriate as a primary financing architecture for the whole challenge.
Type 5: Corporate/Philanthropic In-Kind Partnerships
Definition: Companies provide goods, services, logistics, technology, or expertise rather than cash; foundations provide grants without a return expectation.
UNFPA examples:
- Telecommunications company partnerships for mHealth platforms (mobile health service delivery)
- Tech company partnerships for data analytics (e.g., mapping population displacement with mobile data)
- Pharmaceutical company donations of reproductive health commodities in emergencies
Evidence: In-kind contributions are typically valued at commercial rather than humanitarian prices, creating distorted reporting ("USD 10 million in donated drugs" valued at retail rather than cost price). Strategic coherence is often low — companies donate what they produce, not what communities need.
Relevant to the challenge: In-kind technology partnerships (for community health worker platforms, climate early warning integration, data systems) are realistic and low-controversy entry points. Do not overstate financial value.
EVIDENCE: WHAT WORKS IN HUMANITARIAN PPPs
Where the Evidence Is Strongest
Commodity pooling and procurement: Clear cost reduction evidence. UNFPA's own contraceptive procurement is the most direct example.
Vaccine financing (GAVI model): Strong evidence of coverage expansion and cost per dose reduction. Caution: operates in a relatively stable market environment with commercial upside for manufacturers; less applicable to commodities with no commercial market.
Results-based financing in stable settings: DIBs and OBA have worked where: measurement is straightforward, providers have operational capacity to absorb upfront risk, and political stability allows multi-year contracts.
Where the Evidence Is Weakest / Contested
Blended finance for the poorest populations: Most blended finance flows to middle-income countries and commercially viable sectors. "Commercial returns" cannot be generated from serving displaced populations in Bangladesh or Pacific island communities.
Corporate partnerships for resilience: Corporate partnerships tend to be transactional (logo placement, disaster response PR) rather than structural. Long-term, governance-sharing corporate partnerships that genuinely build community resilience are rare.
Platform PPPs below global level: GAVI and the Global Fund work at global scale with professional secretariats and multi-decade time horizons. Adapting the model to a regional Asia platform is not straightforward; most attempts at regional health PPPs have underperformed.
PPPs in extremely fragile or conflict-affected settings: Evidence is very thin. Private actors withdraw when political risk rises; humanitarian principles are difficult to maintain when profit motives are in play.
DESIGN PRINCIPLES FOR HUMANITARIAN/RESILIENCE PPPs
Based on the evidence above, the following principles are most consistently associated with effective PPPs in humanitarian and development settings:
1. Accountability must be downward to communities, not just upward to funders
The most common failure mode in development PPPs is "funnel accountability" — organisations are accountable to their private sector partners and donors, not to the communities they serve. Mechanisms that have shown promise:
- Community representation on governance boards (Global Fund's CCM model, though imperfect)
- Grievance mechanisms with genuine teeth (not just complaint boxes)
- Participatory monitoring and evaluation where communities assess performance
2. Risk should be shared proportionate to capacity to bear it
Humanitarian PPPs that ask community-level actors or local governments to bear commercial risk (through output-based payments, for example) before capacity is built will fail. Risk-sharing should be calibrated: largest actors (international DFIs, multilateral agencies) absorb the most risk in early phases; risk transfers to local actors only as capacity grows.
3. Community ownership is not the same as community participation
Genuine co-design means communities shape what is built, not just how it is built. The difference matters in practice: community-designed SRHR resilience programmes in South/Southeast Asia have consistently produced different priorities (social support, mobility, safety) from those designed by technical experts without community input.
4. Avoid market distortion in fragile settings
Subsidised private provision that displaces functioning community or government systems can leave communities more vulnerable when the subsidy ends. PPP design should assess: what currently works at community level? What would be crowded out by the partnership?
5. Time horizons must match system change cycles
Building community resilience is a 10–20 year project. Private sector partners typically want 3–5 year return horizons. This mismatch requires either: (a) structuring the PPP in phases with clear milestones and renewal decisions; (b) accepting that private finance plays a catalytic rather than sustaining role; or (c) building in transition mechanisms to government or community ownership from the start.
6. Humanitarian principles as non-negotiables in crisis phases
Humanity, neutrality, impartiality, and independence cannot be compromised in acute humanitarian phases. Private sector partners with commercial interests in the same population (telecom companies, insurance, financial services) may create conflicts. Partnership agreements must define clearly when humanitarian principles override commercial interests.
UNFPA'S EXISTING PRIVATE SECTOR ENGAGEMENT
What UNFPA Currently Does
- Pharmaceutical procurement PPPs: Ongoing. UNFPA negotiates with manufacturers through the Reproductive Health Supplies Coalition and bilateral supplier agreements. This is mature, effective, and central to UNFPA's delivery model.
- Technology partnerships: UNFPA has partnered with digital health companies and data analytics firms (including work on digital health platforms in Asia). Less systematic than procurement partnerships.
- Corporate fundraising: UNFPA has private sector resource mobilisation units that solicit corporate donations and in-kind contributions. Volume is modest.
- Cash Voucher Assistance (CVA): In humanitarian settings, UNFPA increasingly uses cash transfer systems (often in partnership with financial services companies) to allow affected women to access SRHR services. This is a significant area of growth and private sector engagement (WFP, UNHCR lead on cash; UNFPA adapts).
What UNFPA Has Not Done Systematically
- Blended finance structuring or development impact bond design (as distinct from output-based aid in some country programmes)
- Platform partnership governance with private sector (as a board-level co-owner, not just a procurement counterpart)
- Long-term strategic partnerships with Asian philanthropic foundations or family offices
- Structured engagement with Singapore's DFI ecosystem (Temasek Trust, GIC philanthropic arms)
The Gap the LKYSPP Challenge Is Trying to Close
The challenge is explicitly about designing PPPs that go beyond procurement and transactional donations toward strategic, long-term partnerships that build community resilience to climate and humanitarian stressors. This is genuinely new territory for UNFPA and requires: (a) organisational capacity to engage at the finance structuring level; (b) governance frameworks that include communities and civil society; (c) evidence base on what resilience outcomes are achievable through PPP mechanisms in the Asian context.
IMPLICATIONS FOR THE LKYSPP TEAM
Strong evidence exists for:
- Commodity procurement partnerships (build on UNFPA's existing model)
- Platform PPPs at meaningful scale (look to GAVI/Global Fund for governance design)
- Output-based financing for specific, measurable resilience components
Moderate/emerging evidence for:
- Blended finance for climate-SRHR in middle-income Asia (Philippines, Vietnam, Indonesia)
- Digital health PPPs for community-level resilience
Weak or no evidence for:
- Commercial returns from serving the most climate-vulnerable Asian populations (Pacific SIDS, Rohingya, stateless communities)
- Short-term private capital as a substitute for sustained public financing of humanitarian SRHR services
Design recommendations for the team's proposal:
- Frame the PPP as a platform (governance-sharing) model rather than a bilateral contract model — this creates accountability and durability
- Identify a specific, measurable resilience outcome as the anchor (e.g., contraceptive security through climate disruptions in X communities) rather than a broad aspiration
- Include Singapore-based DFIs and family offices as financial partners, not just donors — this requires a structured investment vehicle, not just a fundraising ask
- Build community co-design explicitly into the governance structure, not just as a "consultation" step
- Be honest about time horizon: a credible 10-year plan with 3-year funding tranches is more realistic than a 3-year project claiming systemic impact
SOURCES AND EVIDENCE NOTES
This document synthesises evidence from:
- Convergence: "The State of Blended Finance" (multiple years)
- GAVI: Annual Progress Reports and independent evaluations
- Global Fund: Synthesis reports and CCM effectiveness reviews
- IARAN: "The Future of Aid: Private Sector Engagement in Humanitarian Settings" (2021)
- World Bank: Output-Based Aid dataset and evaluations
- Utkrisht Impact Bond evaluation reports (2021)
- UNFPA: Annual Reports, Strategic Plan 2022–2025, private sector engagement frameworks
Evidence quality rating: Moderate. Large-scale commodity PPPs (GAVI, Global Fund) have strong evidence bases. Blended finance and DIB evidence is improving but remains contested, especially on cost-effectiveness and beneficiary outcomes vs. financial returns. The specific gap — PPPs for climate-SRHR resilience in Asia — has very limited dedicated evidence.